换一批
换一批A prospective open-label trial of Remicade in patients with severe exacerbation of Crohn's disease requiring hospitalization: a comparison with outcomes previously observed in patients receiving intravenous hydrocortisone.
作者：
主题词
成年人(Adult);老年人(Aged);消炎药(Anti-Inflammatory Agents);抗体, 单克隆(Antibodies, Monoclonal);Crohn病(Crohn Disease);女(雌)性(Female);住院(Hospitalization);人类(Humans);氢化可的松(Hydrocortisone);注射, 静脉内(Injections, Intravenous);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);疾病严重程度指数(Severity of Illness Index)
DOI
10.1097/MCG.0b013e31802c2a23
PMID
17667052
发布时间
2015-11-19
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
